UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000036503
Receipt number R000041241
Scientific Title Early mobilization and post intensive care syndrome for critically ill patients in the ICU: multi-center, prospective observational study
Date of disclosure of the study information 2019/06/01
Last modified on 2020/10/13 12:42:45

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Early mobilization and post intensive care syndrome for critically ill patients in the ICU: multi-center, prospective observational study

Acronym

Early mobilization and post intensive care syndrome for critically ill patients: multi-center, prospective observational study (EM-PICS study)

Scientific Title

Early mobilization and post intensive care syndrome for critically ill patients in the ICU: multi-center, prospective observational study

Scientific Title:Acronym

Early mobilization and post intensive care syndrome for critically ill patients: multi-center, prospective observational study (EM-PICS study)

Region

Japan


Condition

Condition

Critically ill patients who are expected to enter in intensive care unit for more than 48 hours.

Classification by specialty

Intensive care medicine Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the relationship between the early mobilization in Japanese intensive care unit and the onset of postintensive care syndrome.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

prevalence of PICS and PICS-F.

Key secondary outcomes

90-day mortality, ICU length of stay, Hospital length of stay, incidence of delirium, incidence of ICU-acquied weakness, duration of mechanical ventilation, activity daily living level, Mobility related items


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients newly admitted in ICU

Key exclusion criteria

Age < 18 years, Patients expected to discharge the ICU within 48 hours, Neurological patients, Patients who are difficult to cooperate in communication and rehabilitation in Japanese, Patients who could not independently able to mobilize prior to the current hospital admission, Treatment is not aimed end of life/terminal care patients

Target sample size

250


Research contact person

Name of lead principal investigator

1st name Yasunari
Middle name
Last name Morita

Organization

National Hospital Organization, Nagoya Medical center

Division name

Department of Emergency and Critical Care Medicine

Zip code

460-0001

Address

4-1-1 Sannomaru, Naka-ku, Nagoya, Aichi 460-0001, Japan.

TEL

052-951-1111

Email

moltlyme2@yahoo.co.jp


Public contact

Name of contact person

1st name Shinichi
Middle name
Last name Watanabe

Organization

National Hospital Organization, Nagoya Medical center

Division name

Department of Rehabilitation Medicine

Zip code

460-0001

Address

4-1-1 Sannomaru, Naka-ku, Nagoya, Aichi 460-0001, Japan.

TEL

052-951-1111

Homepage URL


Email

billabonghonor@yahoo.co.jp


Sponsor or person

Institute

National Hospital Organization, Nagoya Medical center

Institute

Department

Personal name



Funding Source

Organization

Japanese Association for Acute Medicine

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Hospital Organization, Nagoya Medical center

Address

4-1-1 Sannomaru, Naka-ku, Nagoya, Aichi 460-0001, Japan.

Tel

0529511111

Email

billabonghonor@yahoo.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 06 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 06 Month 01 Day

Date of IRB

2019 Year 05 Month 15 Day

Anticipated trial start date

2019 Year 07 Month 01 Day

Last follow-up date

2019 Year 12 Month 31 Day

Date of closure to data entry

2020 Year 07 Month 01 Day

Date trial data considered complete

2020 Year 12 Month 31 Day

Date analysis concluded

2021 Year 03 Month 31 Day


Other

Other related information

(Basic information)
Age, male, height, weight, admission route, Charson Index, presence or absence of dialysis, main cause of ICU admission, sepsis, diabetes, Acute physiology and chronic health evaluation, Sequential organ failure assessment, Drug use at ICU, Extracorporeal membrane oxygenation: With or without
(Rehabilitation information during ICU admission)
Assessment of respiration during rehabilitation: use of mechanical ventilator, oral intubation, tracheotomy.
Assessment of circulation during rehabilitation: use of catecholamine, DOA, DOB, NAD, Epinephrine, Vasopressin.
Assessment of consciousness delirium during rehabilitation
With or without the use of persistent analgesics and sedatives, with pain just before rehabilitation, incidence of delirium.
Other items during rehabilitation: Enteral feeding tube, chest tube, abdominal tube, urine balloon, arterial line, central venous line, presence of drip in inguinal region
Releasing related items in ICU: highest movement level in rehabilitation, nurses participating in rehabilitation, physician, physiotherapist, number of other occupations, ICU mobility scale; achieving IMS Level 3 or higher, IMS Level 3 or higher Cause that was not
Non-rehabilitation interventions in ICU: ABCEDFGHI Bundle.
Adverse events during rehabilitation
(Patient outcome information)
Length of Hospital days, length of ICU days, duration of ventilator, early mobilization related items, Discharge at Barthel Index, Discharge at Medical Research Council sum-score, Discharge at hospital hand grip strength, Hospital Anxiety and Depressions (HADS) at hospital discharge, impact on event scale -reverd (IES-R) at hospital duscharge, EQ-5D-5L at hospital discharge, EQ-5D-5L at after 90 days, HADS at after 90 days, IES-R at after 90 days, HADS of patient family at after 90 days, IES-R of patient family at after 90 days


Management information

Registered date

2019 Year 04 Month 13 Day

Last modified on

2020 Year 10 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041241


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name